
Ironwood Pharmaceuticals IRWD
$ 3.92
1.82%
Quarterly report 2026-Q1
added 05-07-2026
Ironwood Pharmaceuticals Cash Conversion Cycle 2011-2026 | IRWD
Annual Cash Conversion Cycle Ironwood Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 492 | 425 | 402 | 119 | 125 | -159 | 25.9 | -117 | -190 | -3.16 K | -261 K | 54.8 | 657 | -5.68 K | - | 0.08 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 657 | -261 K | -17.9 K |
Quarterly Cash Conversion Cycle Ironwood Pharmaceuticals
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 77.2 | 67.4 | 135 | - | 66.9 | 62.9 | 123 | - | 97.7 | 99.7 | 108 | - | 55 | 56.2 | 121 | 103 | 111 | 104 | 132 | 114 | 102 | 122 | 26.9 | 19.9 | -593 | -16.8 | -776 | 14.7 | -254 | -315 | -538 | 3.09 | -225 | -392 | -2.73 K | 0.97 | 1.29 | 1.57 | 2.64 | 4.94 | 6.65 | -59 | -31.9 K | 0.02 | 5.35 | -13.9 | 172 | 9.3 | 552 | 325 | 180 | 1.55 | 0.43 | 2.86 | 1.98 | 0.21 | 0.55 | 0.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 552 | -31.9 K | -630 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
3.11 K | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-3.12 K | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
-58 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
115 | $ 32.59 | -6.89 % | $ 877 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Celyad Oncology SA
CYAD
|
-55.7 K | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
214 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 7.98 | -1.6 % | $ 5.42 B | ||
|
Autolus Therapeutics plc
AUTL
|
119 | $ 1.7 | 3.03 % | $ 452 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Heron Therapeutics
HRTX
|
751 | $ 0.86 | -1.42 % | $ 143 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-1.6 K | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
-82.7 | $ 2.8 | 7.28 % | $ 262 M | ||
|
Anika Therapeutics
ANIK
|
192 | $ 14.88 | -0.93 % | $ 213 M | ||
|
Advaxis
ADXS
|
-82.3 K | - | -9.65 % | $ 45.9 M | ||
|
Incyte Corporation
INCY
|
-54.7 | $ 97.16 | -0.26 % | $ 19 B | ||
|
Ionis Pharmaceuticals
IONS
|
-556 | $ 75.56 | -0.29 % | $ 12.1 B | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
126 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
149 | $ 1.61 | 2.55 % | $ 189 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 20.86 | -0.71 % | $ 2.65 B |